National Vision (EYE) Soars 2.94% on Citigroup Upgrade

National Vision (EYE) surged 2.94% today, marking its eighth consecutive day of gains, with an impressive 39.71% increase over the past eight days. The share price reached its highest level since May 2024, with an intraday gain of 3.48%.

The strategy of buying EYE shares after they reached a recent high and holding for 1 week yielded moderate returns over the past 5 years. The annualized return was 17.49%, slightly underperforming the market by 2.98 percentage points. With a final value of $2,203.00 for a $1,000 initial investment, the strategy showed the impact of compounded returns on cash growth over time.

Citigroup recently upgraded National Vision Holdings (EYE) from Neutral to Buy, setting a new price target of $21. This upgrade is based on several factors, including National Vision's strong track record of positive performance during economic cycles and its status as a low-cost provider of necessary medical services. The company's recent positive financial results, including a revenue increase of 5.7% in Q1 2025, have also contributed to the upgrade. Additionally, National Vision has raised its fiscal outlook, further driving positive sentiment and suggesting a favorable risk/reward profile for the stock.